))
abrdn's Omstead says the recent healthcare rally is just a start
Manage episode 407247080 series 3561101
Content provided by Active Investment Company Alliance. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Active Investment Company Alliance or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dan Omstead, global head of health care investments at abrdn -- part of the team running the firm's Healthcare Investors, Life Science Investors, Healthcare Opportunities and World Healthcare funds -- says that after several years of struggling, the recent rally in health care and biotech is significant, the start of a positive trend that should be able to withstand the pressures of an election year to keep running higher from here. Omstead identifies a few areas -- most notably the GLP-1 weight management drugs -- that have the potential to not only change the world but to become massive sellers as they make and take over the market.
267 episodes
Share
